[Microperimetry in retinopathies]

Piatigorsky Grinberg N, Bardach A, Argento F, Alfie V, García Martí S, Ciapponi A, Augustovski F, Alcaraz A, Pichon-Riviere A
Record ID 32018002326
Original Title: Microperimetría en oftalmología
Authors' recomendations: No evidence was found to support the use of microperimetry as a method to prevent or slow down decrease in visual acuity in patients with retinopathies. Low-quality evidence suggests that the changes detected by microperimetry in patients with age-related macular degeneration might be correlated with progress in the lesions detected by optical coherence tomography and color fundus photography, and at stages earlier than those detected by these methods. However, the evidence has methodological limitations which does not allow to determine a net benefit resulting from its clinical use. No evidence on the clinical efficacy or diagnostic yield of microperimetry in patients with diabetic retinopathies or other retinopathies has been found. It is not mentioned in the clinical practice guidelines either. No health technology assessments or economic evaluations of microperimetry in ophthalmology have been identified. The clinical practice guidelines identified on age-related macular degeneration do not mention this diagnostic method. None of the coverage policies consulted mention the use of microperimetry in retinopathies.
Project Status: Completed
Year Published: 2021
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: Argentina
MeSH Terms
  • Macular Degeneration
  • Diabetic Retinopathy
  • Hypertensive Retinopathy
  • Visual Field Tests
Organisation Name: Institute for Clinical Effectiveness and Health Policy
Contact Address: Dr. Emilio Ravignani 2024, Buenos Aires - Argentina, C1414 CABA
Contact Name: info@iecs.org.ar
Contact Email: info@iecs.org.ar
Copyright: Institute for Clinical Effectiveness and Health Policy (IECS)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.